Page 79 - FBL AR 2019-20

CORPORATE STATUTORY FINANCIAL
OVERVIEW STATEMENTS STATEMENTS

Following are the core competencies of the Board members as identified and available to the Company for its effective functioning in
terms of Schedule V of Regulation 34(3) of the Listing Regulations:
Names Core Competencies
Mr. Sanjay Buch Corporate and business laws, mergers and acquisitions
Ms. Rajeshwari Datla Pharmaceuticals
Dr. Gopakumar Nair Pharmaceutical industry, mediation and arbitration as well as in licensing and technology transfer
Mr. Vinayak Hajare Investment Banking and Corporate Finance
Mr. Krishna Datla Pharmaceuticals and Real Estate
Mr. Satish Varma Pharmaceuticals and Real Estate
Ms. Anupama Datla Desai Pharmaceuticals
Ms. Rajashri Ojha# Pharmaceuticals, Nutra industry in R&D analytical development, regulatory & QA compliance and
Global registrations
# Appointed w.e.f. April 1, 2020.
The number of directors who have the core competencies is 8, as on the date of the report.
Brief profile of Directors being reappointed, as required under regulation 26(4), 36(3) of the Listing Regulations and secretarial standard on
general meetings specified by the Institute of Company Secretaries of India and approved by the Central Government is provided in page
number 247 of this Annual Report and forms parts of this Corporate Governance Report.

BOARD MEETINGS / PREVIOUS ANNUAL GENERAL MEETING
• During the financial year under review, eight Board Meetings were held on April 08, 2019, May 03, 2019, May 24, 2019, August 05, 2019,
September 26, 2019, November 13, 2019, December 24, 2019 and February 12, 2020. The maximum gap between any two board meetings
was less than 120 days, as stipulated under Regulation 17(2) of the Listing Regulations.
Attendance at the eight Board meetings and previous Annual General Meeting (AGM) held on July 08, 2019 is as follows:
Name Board Meetings attended Attendance at previous AGM
Mr. Sanjay Buch 8 Yes
Ms. Rajeshwari Datla 8 Yes
Mr. Vinayak Hajare 8* Yes
Mr. Krishna Datla 8 Yes
Mr. Satish Varma (appointed as Executive 8 Yes
Director w.e.f. September 27, 2019)
Dr. Gopakumar Nair (appointed w.e.f. May 6 Yes
17, 2019)
Ms. Anupama Datla Desai (appointed 2 N.A.
w.e.f. September 27, 2019)
* Attended one meeting via teleconferencing.
AUDIT COMMITTEE

During the year under review, five Audit Committee meetings were held on April 08, 2019, May 24, 2019, August 05, 2019, November 13,
2019 and February 12, 2020. The representatives of the Auditor(s), and Chief Financial Officer also attended the Audit Committee meeting(s).
The composition of the Audit Committee as on March 31, 2020 and the attendance of the Audit Committee members at the Committee
meetings held during the financial year under review is as follows:
Name of the Director Designation Meetings attended
Mr. Sanjay Buch Chairman 5
Ms. Rajeshwari Datla Member 5
Mr. Vinayak Hajare Member 5*
Dr. Gopakumar Nair (appointed w.e.f. May Member 4
17, 2019)
* Attended one meeting via teleconferencing.

77